Sale!

Life Extension 5-LOX Inhibitor with AspresFlex, 100 mg, 60 Vegetarian Capsules

List Price: $22.00
Our Price: $16.50
Your Savings: $5.50

The body produces a higher than desired level of 5-LOX as we age. Life Extension 5-LOX Inhibitor with AspresFlex absorbs 52% more into the blood stream than other boswellia extracts. This helps to block attacks to joints, arterial walls and other tissuse.

Purchasing this product today earns you 17 DR Reward Points!
SKU: 01639 Category:

Description

5-lipoxygenase (5-LOX) is a member of the lipoxy-genase family of enzymes. It transforms fatty acids into leukotrienes. Excess levels of the enzyme 5-LOX sets in motion inflammatory responses that have been linked to common degenerative effects in aging individuals.9-13

Normal aging results in higher-than-desired levels of 5-LOX.

The typical American diet adds to the danger. Foods rich in omega-6 fatty acids like red meat, poultry, eggs and dairy products, along with high-glycemic carbohy­drates, trigger overproduction of arachidonic acid. In response to high levels of arachidonic acid, the body produces the 5-LOX enzyme.

5-LOX breaks down arachidonic acid to pro-inflam­matory compounds like leukotriene B4,14 a molecule that mediates attacks to joints, arterial walls, and other tissues. 5-LOX itself facilitates undesirable cell division changes.15,16

The good news is that an extract of the Indian plant Boswellia serrata has been shown to neutralize 5-LOX. Used for centuries to help with inflammatory issues, boswellia acts as a natural 5-LOX inhibitor, intervening at the cellular level to block its unwanted effects. Confirmatory data reveal that a compound contained in boswellia called AKBA (3-O-acetyl-11-keto-ß-boswellic acid)17,18 is the key to its beneficial action.

The problem is that boswellia is poorly absorbed into the blood.19 For this reason, a patent-pending, standardized form of boswellia called ApresFlex is being introduced. ApresFlex absorbs into the blood 52% more than previously available boswellia extracts.19

Each 100 mg vegetarian capsule of 5-LOX Inhibitor with ApresFlex is standardized to provide 20% of active AKBA from boswellia. Most people need only one capsule a day.

*It should be noted that although Life Extension®’s previous 5-LOXIN® formulation contained at least a 30% concentration of AKBA, the new ApresFlex formula delivers more AKBA into the bloodstream, offering greater efficacy at a 20% concentration. One capsule of 5-LOX Inhibitor with ApresFlex supplies the same amount of ApresFlex as four vegetarian capsules of the new ArthroMax with Theaflavins & ApresFlex.

 

Supplement Facts

Serving Size: 1 vegetarian capsule

Servings Per Container: 60

Amount Per Serving

ApresFlex (Boswellia serrata) extract (gum resin) [std. to 20% 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) (20 mg)]

100 mg

Other Ingredients: microcrystalline cellulose, vegetable cellulose (capsule), silica, vegetable stearate.

AprèsFlex is a trademark of Laila Nutraceuticals exclusively licensed to PL Thomas – Laila Nutra LLC. International patents pending.

Dosage and Use:

  • To inhibit the 5-lipoxygenase enzyme, take one capsule daily with or without food, or as recommended by a healthcare practitioner.

Warnings:

  • If pregnant, nursing, or taking medication, consult your physician before taking this product
  • Keep out of reach of children
  • Do not exceed recommended dose

References:

1. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial.
2. Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.
9. Neurobiol Aging. 2007 Sep;28(9):1457-62.
10. Cardiovasc Psychiatry Neurol. 2009;2009:174657.
11. Free Radic Biol Med. 2009 Jul 1;47(1):62-71.
12. Rejuvenation Res. 2009 Feb;12(1):15-24.
13. Available at: https://www.cdc.gov/nchs/fastats/lcod.htm. Accessed July 29, 2011.
14. Curr Opin Investig Drugs. 2009 Nov;10(11):1163-72.
15. Carcinogenesis. 2006 Sep;27(9):1902-8.
16. Clin Cancer Res. 2005 Mar 1;11(5):2089-96.
17. Wien Med Wochenschr. 2002;152(15-16):373-8.
18. J Ethnopharmacol. 2006 Sep 19;107(2):249-53.
19. Mol Cell Biochem. 2011 Aug;354(1-2):189-97.

 

* These statements have not been evaluated by the Food and Drug Administration. This Product is not intended to diagnose, treat, cure or prevent any disease.

Reviews

There are no reviews yet.

Be the first to review “Life Extension 5-LOX Inhibitor with AspresFlex, 100 mg, 60 Vegetarian Capsules”

Your email address will not be published.

Please answer the following to suggest you are human. * Time limit is exhausted. Please reload CAPTCHA.